123 related articles for article (PubMed ID: 17566010)
1. Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review.
Leslie WS; Hankey CR; Lean ME
QJM; 2007 Jul; 100(7):395-404. PubMed ID: 17566010
[TBL] [Abstract][Full Text] [Related]
2. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
Miller LJ
Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
[TBL] [Abstract][Full Text] [Related]
3. Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis.
Domecq JP; Prutsky G; Leppin A; Sonbol MB; Altayar O; Undavalli C; Wang Z; Elraiyah T; Brito JP; Mauck KF; Lababidi MH; Prokop LJ; Asi N; Wei J; Fidahussein S; Montori VM; Murad MH
J Clin Endocrinol Metab; 2015 Feb; 100(2):363-70. PubMed ID: 25590213
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
5. Metformin for Weight Gain and Metabolic Abnormalities Associated With Antipsychotic Treatment: Meta-Analysis of Randomized Placebo-Controlled Trials.
Zheng W; Li XB; Tang YL; Xiang YQ; Wang CY; de Leon J
J Clin Psychopharmacol; 2015 Oct; 35(5):499-509. PubMed ID: 26280837
[TBL] [Abstract][Full Text] [Related]
6. Medications associated with weight gain.
Malone M
Ann Pharmacother; 2005 Dec; 39(12):2046-55. PubMed ID: 16278256
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review.
Newall H; Myles N; Ward PB; Samaras K; Shiers D; Curtis J
Int Clin Psychopharmacol; 2012 Mar; 27(2):69-75. PubMed ID: 21979790
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of metformin to limit weight-gain with atypical antipsychotics.
Lee YJ; Jeong JH
J Clin Pharm Ther; 2011 Oct; 36(5):537-45. PubMed ID: 21418264
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
Ellinger LK; Ipema HJ; Stachnik JM
Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced weight gain.
Ness-Abramof R; Apovian CM
Drugs Today (Barc); 2005 Aug; 41(8):547-55. PubMed ID: 16234878
[TBL] [Abstract][Full Text] [Related]
11. Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain?
Vieweg WV; Sood AB; Pandurangi A; Silverman JJ
Acta Psychiatr Scand; 2005 Mar; 111(3):177-84. PubMed ID: 15701101
[TBL] [Abstract][Full Text] [Related]
12. Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis.
Björkhem-Bergman L; Asplund AB; Lindh JD
J Psychopharmacol; 2011 Mar; 25(3):299-305. PubMed ID: 20080925
[TBL] [Abstract][Full Text] [Related]
13. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.
de Silva VA; Dayabandara M; Wijesundara H; Henegama T; Gunewardena H; Suraweera C; Hanwella R
J Psychopharmacol; 2015 Dec; 29(12):1255-61. PubMed ID: 26510448
[TBL] [Abstract][Full Text] [Related]
14. Natalizumab for relapsing remitting multiple sclerosis.
Pucci E; Giuliani G; Solari A; Simi S; Minozzi S; Di Pietrantonj C; Galea I
Cochrane Database Syst Rev; 2011 Oct; (10):CD007621. PubMed ID: 21975773
[TBL] [Abstract][Full Text] [Related]
15. Bodyweight change as an adverse effect of drug treatment. Mechanisms and management.
Pijl H; Meinders AE
Drug Saf; 1996 May; 14(5):329-42. PubMed ID: 8800628
[TBL] [Abstract][Full Text] [Related]
16. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.
Wu RR; Jin H; Gao K; Twamley EW; Ou JJ; Shao P; Wang J; Guo XF; Davis JM; Chan PK; Zhao JP
Am J Psychiatry; 2012 Aug; 169(8):813-21. PubMed ID: 22711171
[TBL] [Abstract][Full Text] [Related]
17. Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies.
Bushe CJ; Bradley AJ; Doshi S; Karagianis J
Int J Clin Pract; 2009 Dec; 63(12):1743-61. PubMed ID: 19840151
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
